Psychiatric Pharmacogenomics: A Practical Guide to Gene-Drug Interactions and Tests
To begin this activity, click Enroll. Once logged in, learners can access educational content, assessments, and evaluations. Learners who successfully complete the activity will be able to print a certificate.
- Describe basic pharmacogenomics concepts.
- Distinguish which gene-drug relationships have the most evidence supporting their implementation in the clinic.
- Identify which psychiatric pharmacogenomics tests to order.
- Confidently formulate medication treatment plans using pharmacogenomics test results.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Michigan Medical School and University of Michigan College of Pharmacy. The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Michigan Medical School designates this enduring material for a maximum of 5.00 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Original Release Date: April 2020
Termination Date: March 2023
Bradley et al. Journal of Psychiatric Research. 2018;96:100-107
Clinical Pharmacogenetics Implementation Consortium (CPIC): cpicpgx.org
FDA Pharmacogenomic Biomarkers Table: https://www.fda.gov/drugs/science-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling
GeneSight Psychotropic: https://genesight.com
Greden, J. F. et al. J. Psychiatr. Res. 111, 59–67 (2019).
NIH Genetic Testing Registry: https://www.ncbi.nlm.nih.gov/gtr/
Pharmacogenomics KnowledgeBase (PharmGKB): https://www.pharmgkb.org
Public Database of Clinical Laboratory Improvement Amendments (CLIA) Tests: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCLIA/search.cfm
